Dr. Ammad-Ud-Din is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12902 USF Magnolia Drive
Tampa, FL 33612
Education & Training
- Rochester General HospitalResidency, Internal Medicine, 2019 - 2022
- Rawalpindi Medical CollegeClass of 2018
Certifications & Licensure
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Spot Urine Protein/Creatinine Ratio as an Alternative to 24-Hour Urine Collection for Measuring Proteinuria in Patients With Multiple Myeloma: A Prospective Study.Saad Jamshed, Mohammad Ammad-Ud-Din, Kimberly Celotto, Irfan Ul Haq Minhas, Jonathan Bress
Clinical Lymphoma, Myeloma & Leukemia. 2025-01-13 - Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis.Julio C Chavez, Ariel Grajales, Jose Sandoval-Sus, Elyce Turba, Lisa Nodzon
Clinical Lymphoma, Myeloma & Leukemia. 2024-06-01 - 9 citationsGeographic and Racial Disparities in Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials Access for Diffuse Large B-Cell Lymphoma.Moazzam Shahzad, Muhammad Fareed Khalid, Muhammad Kashif Amin, Ahmad Basharat, Mohammad Ammad-Ud-Din
Clinical Lymphoma, Myeloma & Leukemia. 2024-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: